Bioavailability, Drug Delivery Systems and Vaccination

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bioavailability

Drug Delivery Systems

Vaccination

Nanoparticles: Emerging Stars for Pharmaceutical Industry

Roots Analysis

FEBRUARY 20, 2022

Over the last decade, one of the major challenges faced by pharmaceutical players across the globe is low drug solubility. In fact, it has been observed that around 40% of the pharmaceutical products approved by regulatory organizations exhibit poor bioavailability / solubility. Our Social Media Platform. Web: [link]. LinkedIn: [link].

Contract Manufacturing

Contract Manufacturing Bioavailability Manufacturing Drug Delivery Systems

Biopharmaceutical Excipient Manufacturing – Current Scenario and Future Trends

Roots Analysis

MARCH 13, 2022

In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines and gene therapies), by the US FDA, have steadily risen. Over the years, the rising popularity of biologics has led to a paradigm shift in the healthcare industry. Our Social Media Platform.

Manufacturing

Manufacturing Drug Delivery Marketing Drug Delivery Systems

Clinical Research Informer

Nanoparticles: Emerging Stars for Pharmaceutical Industry

Biopharmaceutical Excipient Manufacturing – Current Scenario and Future Trends

Stay Connected